Vaccine Compensation Awarded to Stephanie Wilson

Stephanie Wilson, a petitioner, has been awarded compensation through the National Vaccine Injury Compensation Program for her alleged shoulder injury related to vaccine administration (SIRVA) following receipt of an influenza vaccine on October 10, 2022. The settlement was reached through a joint stipulation filed by both parties, stating that Wilson experienced residual effects of her condition for more than six months. Despite Respondent's denial of the claim, the Chief Special Master Corcoran has awarded a lump sum of $90,000.00 to Wilson, representing compensation for all damages that would be available under Section 15(a) of the Vaccine Act.

Key Takeaways:

• Stephanie Wilson was awarded $90,000.00 through the National Vaccine Injury Compensation Program for her alleged SIRVA injury.
• The injury occurred on October 10, 2022, and Wilson experienced residual effects for more than six months.
• The petition was filed on December 14, 2023, and the joint stipulation was filed on May 16, 2025.
• The Respondent denied the claim, but the parties agreed to settle and enter a decision awarding compensation.
• Wilson's counsel will receive the compensation through an ACH deposit in their IOLTA account for prompt disbursement to Wilson.
• The Chief Special Master Corcoran approved the requested amount for Wilson's compensation.

Statistics:

• The amount of compensation awarded to Stephanie Wilson is $90,000.00.
• The petition was filed on December 14, 2023, and the joint stipulation was filed on May 16, 2025.
• The time frame between the alleged injury and the filing of the petition is approximately 1 year and 5 months.
• The time frame between the filing of the petition and the joint stipulation is approximately 4 months.

Sources:

• In re Wilson, No. 23-2124V, 2023 WL 7282921 (Fed. Cl. June 18, 2025)
• Joint Stipulation, filed May 16, 2025, in the United States Court of Federal Claims